key: cord-0055065-3maqs35l authors: Villa, Alessandro; Chmieliauskaite, Milda; Patton, Lauren L. title: Including vaccinations in the scope of dental practice: The time has come date: 2021-01-09 journal: J Am Dent Assoc DOI: 10.1016/j.adaj.2020.09.025 sha: 8982000a825eb9e965fef6958252b87ad162def9 doc_id: 55065 cord_uid: 3maqs35l nan in primary prevention for oropharyngeal cancers. 18 Furthermore, dentists usually see patients twice as often as primary care physicians and perform comprehensive oral cancer screenings, indicating that dentists play a key role in secondary prevention of oropharyngeal cancers through early detection of potentially malignant and malignant lesions. 19, 20 One concern of dentists might be how vaccination discussions and delivery would be perceived by patients or parents of minors. A 2020 study from Minnesota reported the attitudes of parents (n ΒΌ 208) of adolescents aged 9 through 17 years on the role of dentists in HPV prevention. 21 Most of the parents believed dental providers were well qualified to discuss HPV and administer HPV vaccines, suggesting once again that patients appreciate cancer prevention education in dental settings. Among a majority racial and ethnic minority population of parents of children attending a school-based pediatric dental clinic in Louisiana, 79% indicated acceptance of vaccines delivered by dentists, making dentistdelivered HPV vaccines an additional pathway to addressing health disparities. 22 Oropharyngeal cancer is now the most common cancer attributed to HPV in the United States, surpassing rates of cervical cancer in 2019. 23 Yet, data have shown a constant decline in the awareness of HPV and HPV vaccine since 2013 in the United States. 24 The HPV vaccine represents a safe and effective tool approved by the US Food and Drug Administration in 2020 for the prevention of oropharyngeal cancers. 25 Millions of doses of the HPV vaccine have been administered so far with few to no adverse effects. 26 By increasing HPV vaccination rates, the medical and dental community would be able to prevent thousands of cancers. The HPV nonavalent vaccine (Gardasil 9, licensed in 2014) is available in the United States for the prevention of HPV-related conditions. It contains noninfectious protein antigens for HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. 27,28 The American Cancer Society recommends routine HPV vaccination from the age of 9 through 12 years. 29 However, the vaccine can be administered as early as 9 years. Catch-up HPV vaccination is recommended for all people through age 26 years who are not adequately vaccinated. We acknowledge that there are several barriers that will need to be addressed including vaccine storage, reimbursement, and vaccine tracking records. In addition, comprehensive skills-based training should be integrated into existing dental education programs. The US Centers for Disease Control and Prevention provides interactive, web-based, immunization training through its program called "You Call The Shots," with topics of relevance to this discussion covering general best practice guidelines on immunization, vaccine storage and handling, and HPV. 30 We believe legislative empowerment of dentists to administer vaccines will be the first step in improving access to immunization programs to help prevent transmittable infectious diseases and HPV-associated cancers. The time to act as an advocate for our patients and our profession with our state dental boards and state legislatures regarding the dental practice act and involvement of dentists in vaccination efforts is now. n Bringing resources to state, local, tribal, & territorial governments: US Department of Homeland Security Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration: United States Vaccine rates drop dangerously as parents avoid doctor's visits Outcomes of oral cancer early detection and prevention statewide model in Maryland Community water fluoridation benefits US children from poor families more than those from more affluent families Vaccines, epidemics, pandemics and us American Dental Association. ADA adopts policy on HPV vaccination for the prevention of oral HPV infection Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: umbrella review of systematic reviews USA dental health providers' role in HPV vaccine communication and HPV-OPC protection: a systematic review Dental professionals' knowledge, attitudes, and practice behaviors related to human papillomavirus vaccination attitudes and practices regarding human papilloma virus communication and vaccine advocacy among Minnesota dentists and dental hygienists Council on Scientific AffairsAn American Dental Association Clinical Evaluators Panel survey Minnesota Department of Human Services. Immunizations and vaccinations Illinois General Assembly. Section 1220.403: Dentists administering flu vaccines Regular Session, House Bill 2220 A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health Impact of pharmacists as immunizers on vaccination rates: a systematic review and meta-analysis Evaluating the effectiveness of human papillomavirus educational intervention among oral health professionals Exploring awareness, attitudes, and perceived role among oral health providers regarding HPV-related oral cancers Evidencebased clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association Parent perceptions of dental care providers' role in human papillomavirus prevention and vaccine advocacy Declining awareness of HPV and HPV vaccine within the general US population The ASCO Post Staff. FDA approves nine-valent HPV vaccine for the prevention of certain HPV-related head and neck cancers: Gardasil 9 now approved for the prevention of HPV-related cervical, vaginal, vulvar, anal, oropharyngeal, and other head and neck cancers Adverse events following HPV vaccination: 11 years of surveillance in Australia US Food and Drug Administration. Gardasil 9 Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation